硫酸瑞美吉泮是一种降钙素基因相关肽 (CGRP) 受体竞争性拮抗剂。
包装: 1kg/袋; 25kg/桶或按需分装
供货情况: 现货供应

密封置于阴凉干燥、避光处，常温运输。

[1]. Guanglin Luo, et al. Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine. Journal of Medicinal Chemistry. 02 Nov 2012 [2]. Nekomoto A, et al. Feasibility of administration of calcitonin gene-related peptide receptor antagonist on attenuation of pain and progression in osteoarthritis. Sci Rep. 2023;13(1):15354. Published 2023 Sep 16. [3]. Pistolesi A, et al. Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis. Cephalalgia. 2025;45(11):3331024251378713. [4]. Mulder IA, et al. Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice. Ann Neurol. 2020;88(4):771-784. [5]. Ike E, et al. Calcitonin Gene-Related peptide receptor antagonist suppresses allergic asthma responses via downregulation of group 2 innate lymphoid cells in mice. Int Immunopharmacol. 2023;122:110608.